Table 2. Demographical and clinico-pathological profile of cervical cancer subjects in the study.

Characteristics	Number of cases [%age]
	HPV positive (N = 72) [84.70]	HPV negative (N = 13) [15.29]
Age group
18–30 years	08 [11.11]	01 [7.69]
31–40 years	26 [36.11]	08 [61.53]
41–50 years	19 [26.38]	02 [15.38]
51–60 years	19 [26.38]	02 [15.38]
Menopausal status
Pre-Menopausal	44 [61.11]	10 [76.92]
Post-Menopausal	28 [38.88]	03 [23.07]
Histological type
Well differentiated SCC	43 [59.72]	07 [53.84]
Moderately differentiated SCC	21 [29.16]	04 [30.76]
Poorly differentiated SCC	08 [11.11]	02 15.38]
Stage
IIA	32 [44.44]	05 [38.46]
IIB	16 [22.22]	04 [30.76]
IIIA	09 [12.5]	02 [15.38]
IIIB	11 [15.27]	02 [15.38]
IV	04 [5.55]	00 [0.00]
Gravida	4.59 (Mean)
HPV genotype			NA
HPV16	72 [100.00]
HPV18	00 [0.00]